| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00262660 |
| P698 | PubMed publication ID | 4095829 |
| P2093 | author name string | H G Tiselius | |
| P2860 | cites work | Risk Factors in Calcium Stone Disease of the Urinary Tract | Q39262482 |
| Inhibitors and promoters of stone formation | Q39728243 | ||
| Crystallization of calcium oxalate from synthetic urine | Q43477645 | ||
| A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. | Q52702224 | ||
| An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. | Q52718055 | ||
| Saturation-Inhibition Index as a Measure of the Risk of Calcium Oxalate Stone Formation in the Urinary Tract | Q67431781 | ||
| A new urinary test for stone "activity" | Q67455024 | ||
| Supersaturation levels and crystallization rates of calcium oxalate from urines of normal humans and stone formers determined by a 14C-oxalate technique | Q68858977 | ||
| Determination of urinary oxalate by reversed-phase ion-pair "high-performance" liquid chromatography | Q70476149 | ||
| Independent assessment of the growth and aggregation of calcium oxalate crystals using the Coulter counter | Q70685289 | ||
| Variations in urine composition during the day in patients with calcium oxalate stone disease | Q70788685 | ||
| Biochemical evaluation of patients with urolithiasis | Q71474625 | ||
| Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples | Q71508650 | ||
| New methods to determine the state of saturation of urine and to discriminate between the urine of control subjects and stoneformers | Q71822613 | ||
| P433 | issue | 6 | |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 297-300 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Urological Research | Q15746542 |
| P1476 | title | Measurement of the risk of calcium oxalate crystallization in urine. | |
| P478 | volume | 13 |
| Q38036644 | Clinical investigations |
| Q54419864 | Crystallization Properties in Urine from Calcium Oxalate Stone Formers |
| Q51612622 | Crystalluria determined by polarization microscopy. Technique and results in healthy control subjects and patients with idiopathic recurrent calcium urolithiasis classified in accordance with calciuria. |
| Q68733886 | Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate |
| Q67247156 | Effects of urinary macromolecules on the crystallization of calcium oxalate |
| Q73888400 | Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers |
| Q67967002 | Inhibition of calcium oxalate crystallization by urinary macromolecules |
| Q41583027 | Intratubular crystallization events |
| Q71347684 | Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine? |
| Q69045056 | Measurement of the risk of calcium phosphate crystallization in urine |
| Q40912345 | Risk formulas in calcium oxalate urolithiasis |
| Q38236336 | Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate? |
| Q45938618 | Studies of urinary calcium oxalate crystallization in clinical research. |
| Q69558122 | Urolithiasis--historical, comparative and pathophysiological aspects: a review |
Search more.